Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JINTROLONG for Transitional Growth Hormone Deficiency
ChiCTR2100048579Phase 4Recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Aug 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of peg-somatropin in growth hormone deficiency (GHD), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoint: Body composition. Started Aug 2021; status: recruiting.
02
Drugs
peg-somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on ChiCTR2100048579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048579.